Mary M. McDermott

Professor, Feinberg School of Medicine · Feinberg School of Medicine

Credentials: · · ·

History

IMProving Mobility After revasCularizaTion in Peripheral Artery Disease: The IMPACT PAD Trial
National Heart, Lung, and Blood Institute · UH3
Contact PI · $2.8M · Northwestern University
2024–2031
NICotinamidE Riboside to Improve Functioning in PAD: The NICE Trial
National Institute on Aging · R01
Contact PI · $773.5K · Northwestern University
2026–2031
Urolithin A to Improve Mitochondria and Mobility in Peripheral Artery Disease: Urolithin for PAD Trial
National Institute on Aging · R21
Contact PI · $214K · Northwestern University
2026–2028
Response to Exercise and Nitric Oxide in PAD: The RESIST PAD Trial
National Institute on Aging · R01
Contact PI · $2.7M · Northwestern University
2023–2028

The NICE-PAD II Trial
Principal investigator · Not yet recruiting · Phase 3
Northwestern University
2026–2031
The COCOA-PAD II Trial
Principal investigator · Recruiting · Phase 3
Northwestern University
2021–2027
Unacylated Ghrelin to Improve Functioning in PAD
Principal investigator · Completed · Phase 2
Northwestern University
2020–2025
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
Principal investigator · Recruiting
Northwestern University
2020–2027